Stocklytics Platform
Asset logo for symbol TWST
Twist Bioscience
TWST69
$54.07arrow_drop_up1.36%$0.73
Asset logo for symbol TWST
TWST69

$54.07

arrow_drop_up1.36%
Key Stats
Open$53.25
Prev. Close$53.30
EPS-3.60
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range52.48
55.23
52 Week Range14.42
60.90
Ratios
EPS-3.60
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

TWST-
US Healthcare Sector-
US Market-
check_circle

TWST / Market

TWST exceeded the US Market which returned 0.66% over the last twenty four hours.
warning

TWST / Healthcare Sector

TWST lose to the US Healthcare sector which returned 2.53% over the last twenty four hours.

Twist Bioscience (TWST) Statistics

Twist Bioscience Corp (TWST) is a leading provider of high-quality synthetic DNA. The company offers a range of products and services for the biotechnology and pharmaceutical industries. With a strong focus on innovation and technology, Twist Bioscience Corp is at the forefront of the genomics revolution. Its mission is to improve human health and sustain the planet through the power of synthetic biology.
When evaluating the valuation metrics of Twist Bioscience Corp, it is important to consider various factors. The stock statistics indicate that TWST has shown strong performance in recent years. The fundamentals of the company are also robust, with a solid revenue per share and a healthy profit margin. Additionally, Twist Bioscience Corp has a relatively low level of total debt, which is a positive indicator of its financial health.
add Twist Bioscience to watchlist

Keep an eye on Twist Bioscience

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Twist Bioscience (TWST) stock's performance compared to its sector and the market over the past year?

Over the past year, Twist Bioscience (TWST) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.58%, Twist Bioscience has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.22%, it has fallen short of the market average. This comparison highlights Twist Bioscience's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Twist Bioscience (TWST) stock?

The PE ratio for Twist Bioscience (TWST) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Twist Bioscience (TWST) stock?

The Earnings Per Share (EPS) for Twist Bioscience (TWST), calculated on a diluted basis, is -$3.6. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Twist Bioscience (TWST) stock?

The operating margin for Twist Bioscience (TWST) is -54%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Twist Bioscience (TWST) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Twist Bioscience (TWST) is -$156.67M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Twist Bioscience (TWST) have?

Twist Bioscience (TWST) has a total debt of $87.18M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$141.29M.

Take Your Investments to a Whole New Level